Diab – a Ratos company

Diab is since 2009 wholly owned by Ratos, a private equity conglomerate listed on Nasdaq Stockholm, Large Cap. Ratos’s business concept is to generate, over time, the highest possible return through the professional, active and responsible exercise of its ownership role.